المؤلفون: Monteverde M; Laboratory of Cancer Genetics and Translational Oncology, Oncology Department, S. Croce General Hospital, Via Carle 25, 12100, Cuneo, Italy., Milano G; Oncopharmacology unit, Centre Antoine Lacassagne, Nice, France., Strola G; Laboratory Department, S. Croce General Hospital, Cuneo, Italy., Maffi M; Laboratory of Cancer Genetics and Translational Oncology, Oncology Department, S. Croce General Hospital, Via Carle 25, 12100, Cuneo, Italy., Lattanzio L; Laboratory of Cancer Genetics and Translational Oncology, Oncology Department, S. Croce General Hospital, Via Carle 25, 12100, Cuneo, Italy., Vivenza D; Laboratory of Cancer Genetics and Translational Oncology, Oncology Department, S. Croce General Hospital, Via Carle 25, 12100, Cuneo, Italy., Tonissi F; Laboratory of Cancer Genetics and Translational Oncology, Oncology Department, S. Croce General Hospital, Via Carle 25, 12100, Cuneo, Italy., Merlano M; Medical Oncology, Oncology Department, S. Croce General Hospital, Cuneo, Italy., Lo Nigro C; Laboratory of Cancer Genetics and Translational Oncology, Oncology Department, S. Croce General Hospital, Via Carle 25, 12100, Cuneo, Italy. Electronic address: lonigro.c@ospedale.cuneo.it.

المصدر: Critical reviews in oncology/hematology [Crit Rev Oncol Hematol] 2015 Aug; Vol. 95 (2), pp. 179-90. Date of Electronic Publication: 2015 Mar 12.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Review

بيانات الدورية: Publisher: Elsevier Scientific Publishers Country of Publication: Netherlands NLM ID: 8916049 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0461 (Electronic) Linking ISSN: 10408428 NLM ISO Abbreviation: Crit Rev Oncol Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal/*therapeutic use , Antibodies, Neoplasm/*therapeutic use , Antibody-Dependent Cell Cytotoxicity/*drug effects , Cetuximab/*therapeutic use , Drug Delivery Systems/*methods , ErbB Receptors/*antagonists & inhibitors , Neoplasms/*drug therapy, ErbB Receptors/metabolism ; Humans ; Neoplasms/metabolism ; Neoplasms/pathology ; Panitumumab

المؤلفون: Sibéril S; Unité INSERM 255, IFR58, Université René Descartes-Paris 5, Université Pierre et Marie Curie-Paris 6, Centre de Recherches Biomédicales des Cordeliers, Paris, France., Dutertre CA, Fridman WH, Teillaud JL

المصدر: Critical reviews in oncology/hematology [Crit Rev Oncol Hematol] 2007 Apr; Vol. 62 (1), pp. 26-33. Date of Electronic Publication: 2007 Jan 19.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Review

بيانات الدورية: Publisher: Elsevier Scientific Publishers Country of Publication: Netherlands NLM ID: 8916049 Publication Model: Print-Electronic Cited Medium: Print ISSN: 1040-8428 (Print) Linking ISSN: 10408428 NLM ISO Abbreviation: Crit Rev Oncol Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal/*therapeutic use , Antigens, CD/*immunology , Drug Delivery Systems/*methods , Drug Delivery Systems/*trends , Receptors, IgG/*immunology, Animals ; Antibodies, Monoclonal/chemistry ; Antibodies, Monoclonal/immunology ; Antibody Specificity ; Antigens, CD/chemistry ; Antigens, CD/genetics ; Humans ; Receptors, IgG/chemistry ; Receptors, IgG/genetics

المؤلفون: Huober J; Breast Centre, Kantonsspital, St. Gallen, Switzerland. jens.huober@kssg.ch, Thürlimann B

المصدر: Critical reviews in oncology/hematology [Crit Rev Oncol Hematol] 2010 Apr; Vol. 74 Suppl 1, pp. S7-10.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Elsevier Scientific Publishers Country of Publication: Netherlands NLM ID: 8916049 Publication Model: Print Cited Medium: Internet ISSN: 1879-0461 (Electronic) Linking ISSN: 10408428 NLM ISO Abbreviation: Crit Rev Oncol Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal/*therapeutic use , Antineoplastic Agents/*therapeutic use , Bone Density Conservation Agents/*therapeutic use , Bone Neoplasms/*drug therapy , Bone Neoplasms/*secondary , Bone and Bones/*drug effects , Breast Neoplasms/*pathology , Diphosphonates/*therapeutic use , RANK Ligand/*therapeutic use, Antibodies, Monoclonal, Humanized ; Bone and Bones/pathology ; Breast Neoplasms/drug therapy ; Denosumab ; Drug Delivery Systems ; Female ; Humans

المؤلفون: Dassonville O; Centre Antoine Lacassagne, Laboratoire d'Oncopharmacologie, 33 Avenue de Vallombrose, 06189 Nice, France., Bozec A, Fischel JL, Milano G

المصدر: Critical reviews in oncology/hematology [Crit Rev Oncol Hematol] 2007 Apr; Vol. 62 (1), pp. 53-61. Date of Electronic Publication: 2007 Feb 26.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Elsevier Scientific Publishers Country of Publication: Netherlands NLM ID: 8916049 Publication Model: Print-Electronic Cited Medium: Print ISSN: 1040-8428 (Print) Linking ISSN: 10408428 NLM ISO Abbreviation: Crit Rev Oncol Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal/*therapeutic use , Antineoplastic Agents/*therapeutic use , ErbB Receptors/*antagonists & inhibitors , ErbB Receptors/*drug effects , Neoplasms/*drug therapy , Protein Kinase Inhibitors/*therapeutic use, Animals ; Antibodies, Monoclonal/immunology ; Clinical Trials as Topic ; Drug Delivery Systems/methods ; Humans ; Protein Kinase Inhibitors/metabolism ; Protein-Tyrosine Kinases/antagonists & inhibitors ; Protein-Tyrosine Kinases/drug effects

المؤلفون: Desoize B

المصدر: Critical reviews in oncology/hematology [Crit Rev Oncol Hematol] 2007 Apr; Vol. 62 (1), pp. 23-5.

نوع المنشور: Comment; Editorial

بيانات الدورية: Publisher: Elsevier Scientific Publishers Country of Publication: Netherlands NLM ID: 8916049 Publication Model: Print Cited Medium: Print ISSN: 1040-8428 (Print) Linking ISSN: 10408428 NLM ISO Abbreviation: Crit Rev Oncol Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal/*therapeutic use , Drug Delivery Systems/*methods , Neoplasms/*drug therapy , Neoplasms/*immunology, Animals ; Antigens, Neoplasm/immunology ; Humans